That's a turn around on your part, and long overdue
I've always been on the record as supporting this. Trade US rights for cash and a %royalty. Keep ROW. Eventually sell ROW and US royalty % en bloc, hopefully to the same entity that buys the US rights. Immediate cash in bank, no need for further cap raises and sp rises and immediate start on FDA by a committed partner.
You've always been negative about it.
OSL will never have the capital to undertake pivotal US FDA trials for ca pancreas.
Why OSL is a Multi-Bagger, page-13
-
- There are more pages in this discussion • 43 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add OSL (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
1.0¢ |
Change
-0.002(16.7%) |
Mkt cap ! $37.84M | |||
| Open | High | Low | Value | Volume |
| 1.1¢ | 1.1¢ | 0.9¢ | $218.9K | 21.56M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 2091748 | 1.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 1.1¢ | 3140000 | 5 |
View Market Depth
| Last trade - 15.58pm 08/08/2024 (20 minute delay) ? |
| OSL (ASX) Chart |